Caricamento...
Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
BACKGROUND: Trastuzumab therapy given in combination with one of several chemotherapy regimens is currently considered the standard of care for the treatment of early-stage, human epidermal growth factor receptor-2 (HER2) -positive breast cancer. The treatment with trastuzumab is due to a significan...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Versita, Warsaw
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4078028/ https://ncbi.nlm.nih.gov/pubmed/24991199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2013-0040 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|